Goal-directed Neoadjuvant Treatment of Operable Pancreatic Cancer: Achieving CA19-9 Normalization to Chemotherapy Prior to Surgery. (2022) - Thalji, S.; Aldakkak, M.; Christians, K.; Clarke, C.; George, B.; Kamgar, M.; Erickson, B.; Hall, W.; Khan, A.; Tolat, P.; Giorgadze, T.; Evans, D.; et al.